The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Sector
N/A
Industry
N/A
Country
N/A
Exchange
NGM
Market Cap
1.0 billion USD
Current Price
105.82 USD
52 Week High
99.51 USD
52 Week Low
77.67 USD
P/E Ratio
23.76
Dividend Yield
1.93%
| Symbol | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PPH | -2% | 14% | 9% | -20% | 17% | 1% | 16% | 8% | 35% | 24% | 3% | -16% | 14% | -6% | 20% | 5% | 17% | 2% | 6% | 8% | 20% | 3% | 8% |